MetLife Investment Management’s Ormat Technologies ORA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.09M Buy
65,122
+3,130
+5% +$388K 0.03% 499
2026
Q1
$6.94M Sell
61,992
-212
-0.3% -$24.6K 0.04% 484
2025
Q4
$6.87M Sell
62,204
-3,767
-6% -$412K 0.03% 481
2025
Q3
$6.35M Sell
65,971
-465
-0.7% -$41.9K 0.03% 530
2025
Q2
$5.56M Buy
66,436
+1,502
+2% +$112K 0.03% 532
2025
Q1
$4.6M Sell
64,934
-1,020
-2% -$69.1K 0.02% 653
2024
Q4
$4.47M Buy
65,954
+8,021
+14% +$620K 0.02% 624
2024
Q3
$4.46M Sell
57,933
-488
-0.8% -$36.2K 0.03% 594
2024
Q2
$4.19M Buy
58,421
+2,382
+4% +$165K 0.02% 594
2024
Q1
$3.71M Sell
56,039
-1,393
-2% -$93K 0.02% 658
2023
Q4
$4.35M Sell
57,432
-428
-0.7% -$29.1K 0.03% 547
2023
Q3
$4.05M Sell
57,860
-776
-1% -$60.2K 0.03% 538
2023
Q2
$4.72M Buy
58,636
+126
+0.2% +$10.7K 0.03% 478
2023
Q1
$4.96M Buy
58,510
+3,075
+6% +$270K 0.04% 445
2022
Q4
$4.79M Buy
55,435
+2,742
+5% +$246K 0.04% 460
2022
Q3
$4.54M Buy
52,693
+29,080
+123% +$2.59M 0.04% 457
2022
Q2
$1.85M Sell
23,613
-482
-2% -$38K 0.01% 930
2022
Q1
$1.97M Buy
24,095
+8,812
+58% +$645K 0.01% 997
2021
Q4
$1.21M Sell
15,283
-995
-6% -$75.1K 0.01% 1050
2021
Q3
$1.08M Hold
16,278
0.01% 1084
2021
Q2
$1.13M Hold
16,278
0.01% 1096
2021
Q1
$1.28M Buy
16,278
+349
+2% +$34.6K 0.01% 1033
2020
Q4
$1.44M Sell
15,929
-1,312
-8% -$99.3K 0.01% 970
2020
Q3
$1.02M Hold
17,241
0.01% 1017
2020
Q2
$1.09M Buy
17,241
+783
+5% +$51.2K 0.01% 996
2020
Q1
$1.11M Hold
16,458
0.02% 858
2019
Q4
$1.23M Sell
16,458
-1,296
-7% -$98.1K 0.01% 997
2019
Q3
$1.32M Hold
17,754
0.01% 943
2019
Q2
$1.13M Buy
17,754
+932
+6% +$55.5K 0.01% 1055
2019
Q1
$928K Hold
16,822
0.01% 1114
2018
Q4
$880K Hold
16,822
0.01% 1070
2018
Q3
$910K Sell
16,822
-2,047
-11% -$109K 0.01% 1174
2018
Q2
$1M Hold
18,869
0.01% 1011
2018
Q1
$1.06M Hold
18,869
0.01% 979
2017
Q4
$1.21M Buy
+18,869
New +$1.2M 0.01% 959

Other funds holding ORA

MetLife Investment Management's ORA Position: Q2 2026 in Review

MetLife Investment Management increased its Ormat Technologies (ORA) stake by 5% in Q2 2026, buying an estimated $388K and bringing the position to 65,122 shares worth $7.09M. The position accounts for 0.03% of the portfolio, ranked #499.

MetLife Investment Management first reported a position in ORA in Q4 2017 and has held it in 35 quarters since. 431 funds tracked by Wall St. Rank hold ORA as of Q2 2026.

  • MetLife Investment Management held 65,122 shares of Ormat Technologies worth $7.09M as of Q2 2026.
  • MetLife Investment Management bought 3,130 Ormat Technologies shares in Q2 2026, an estimated $388K.
  • Ormat Technologies made up 0.03% of MetLife Investment Management's portfolio in Q2 2026, its #499 holding.
  • MetLife Investment Management first reported a position in Ormat Technologies in Q4 2017 and has held it in 35 quarters since.
  • 431 funds tracked by Wall St. Rank held Ormat Technologies as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.